MARKET

IRME

IRME

Ir-Med Inc
EXMKT
0.050
NaN%
Closed 09:30 01/15 EST
OPEN
--
PREV CLOSE
0.050
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.510
52 WEEK LOW
0.010
MARKET CAP
4.68M
P/E (TTM)
-1.5260
1D
5D
1M
3M
1Y
5Y
1D
IR-Med Amends Executive Compensation Amid Financial Struggles
TipRanks · 12/12/2025 21:34
IR-MED Inc. Delays Q3 2025 Financial Report
Reuters · 12/12/2025 21:06
IR-MED Ltd. Announces Launch of First-in-Human Clinical Trial of Its DiaSafe(TM) Device for Diabetic Foot Ulcer (DFU) Assessment
Newsfile · 11/03/2025 21:30
IR-MED Unveils Clinical Results for PressureSafe AI-Powered Skin Assessment Platform
Reuters · 10/27/2025 20:08
IR-MED's Key Clinical and Media Milestones
Newsfile · 10/27/2025 20:05
IR-MED Inc. Completes Private Placement Offering, Issuing 1.56M Shares and Warrants for Additional 781K Shares, CEO Purchases Significant Stake
Reuters · 09/23/2025 15:16
IR-Med Completes Private Placement Offering
TipRanks · 09/22/2025 12:31
IR-MED Inc. Announces New Clinical Trial at Major U.S. Hospital for PressureSafe™ Device, Targeting Broader Adoption in Healthcare Market
Reuters · 09/16/2025 20:06
More
About IRME
IR-Med, Inc. is in the process of developing point-of-care decision support devices based on a patented infrared spectroscopy and artificial intelligence (AI) analysis technology platform. PressureSafe, the Company’s first product based on this platform, is a handheld device designed to revolutionize the assessment of pressure injuries (PI) affecting skin and underlying tissue. The Company is developing its technology through its subsidiary and is utilizing Infra-Red-light spectroscopy (IR) combined with an artificial intelligence (AI) technology platform to develop non-invasive devices for various medical indications, by assessing various biomarkers and molecules in the blood and in human tissue in real-time. The second product candidate, DiaSafe, which is under development, is a non-invasive, user-friendly device which is designed to address medical needs by offering assessment of Diabetic Foot Ulcer (DFU) before skin breakage.

Webull offers IR-Med Inc stock information, including EXMKT: IRME real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRME stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IRME stock methods without spending real money on the virtual paper trading platform.